Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

An HIV epidemic model based on viral load dynamics: value in assessing empirical trends in HIV virulence and community viral load.

Herbeck JT, Mittler JE, Gottlieb GS, Mullins JI.

PLoS Comput Biol. 2014 Jun 19;10(6):e1003673. doi: 10.1371/journal.pcbi.1003673. eCollection 2014 Jun.

PMID:
24945322
[PubMed - in process]
Free PMC Article
2.

Higher Expression of Activating Receptors on Cytotoxic NK Cells is Associated with Early Control on HIV-1C Multiplication.

Kulkarni AG, Paranjape RS, Thakar MR.

Front Immunol. 2014 May 16;5:222. doi: 10.3389/fimmu.2014.00222. eCollection 2014.

PMID:
24904577
[PubMed]
Free PMC Article
3.

CD4 counts and viral loads of newly diagnosed HIV-infected individuals: implications for treatment as prevention.

Govender S, Otwombe K, Essien T, Panchia R, de Bruyn G, Mohapi L, Gray G, Martinson N.

PLoS One. 2014 Mar 4;9(3):e90754. doi: 10.1371/journal.pone.0090754. eCollection 2014.

PMID:
24595317
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment.

Shiau S, Kuhn L, Strehlau R, Martens L, McIlleron H, Meredith S, Wiesner L, Coovadia A, Abrams EJ, Arpadi SM.

BMC Pediatr. 2014 Feb 12;14:39. doi: 10.1186/1471-2431-14-39.

PMID:
24521425
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis.

Roff SR, Noon-Song EN, Yamamoto JK.

Front Immunol. 2014 Jan 13;4:498. doi: 10.3389/fimmu.2013.00498. eCollection 2014 Jan 13. Review.

PMID:
24454311
[PubMed]
Free PMC Article
6.

Immune activation and collateral damage in AIDS pathogenesis.

Miedema F, Hazenberg MD, Tesselaar K, van Baarle D, de Boer RJ, Borghans JA.

Front Immunol. 2013 Sep 26;4:298. doi: 10.3389/fimmu.2013.00298. Review.

PMID:
24133492
[PubMed]
Free PMC Article
7.

17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription.

Szotek EL, Narasipura SD, Al-Harthi L.

Virology. 2013 Sep 1;443(2):375-83. doi: 10.1016/j.virol.2013.05.027. Epub 2013 Jun 12.

PMID:
23769242
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Higher expression of several interferon-stimulated genes in HIV-1-infected females after adjusting for the level of viral replication.

Chang JJ, Woods M, Lindsay RJ, Doyle EH, Griesbeck M, Chan ES, Robbins GK, Bosch RJ, Altfeld M.

J Infect Dis. 2013 Sep 1;208(5):830-8. doi: 10.1093/infdis/jit262. Epub 2013 Jun 10.

PMID:
23757341
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Evaluation of the adverse reactions of antiretroviral drug regimens in a tertiary care hospital.

Rather ZA, Chowta MN, Prakash Raju GJ, Mubeen F.

Indian J Pharmacol. 2013 Mar-Apr;45(2):145-8. doi: 10.4103/0253-7613.108294.

PMID:
23716890
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.

Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G, Frank I; HVTN 906 Study Team.

J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):239-44. doi: 10.1097/QAI.0b013e31828ded1a.

PMID:
23446497
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.

Wada N, Jacobson LP, Cohen M, French A, Phair J, Muñoz A.

Am J Epidemiol. 2013 Jan 15;177(2):116-25. doi: 10.1093/aje/kws321. Epub 2013 Jan 3.

PMID:
23287403
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trials.

Metch B, Frank I, Novak R, Swann E, Metzger D, Morgan C, Lucy D, Dunbar D, Graham P, Madenwald T, Escamilia G, Koblin B.

AIDS Behav. 2013 Feb;17(2):760-72. doi: 10.1007/s10461-012-0351-6.

PMID:
23090677
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Hemoglobin may contribute to sex differences in mortality among HIV-infected persons in care.

Melekhin VV, Shepherd BE, Stinnette SE, Rebeiro PF, Turner MM, Sterling TR.

PLoS One. 2012;7(9):e44999. doi: 10.1371/journal.pone.0044999. Epub 2012 Sep 13.

PMID:
23028732
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Immune cells have sex and so should journal articles.

Klein SL.

Endocrinology. 2012 Jun;153(6):2544-50. doi: 10.1210/en.2011-2120. Epub 2012 Mar 20. Review.

PMID:
22434079
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Efficient use of longitudinal CD4 counts and viral load measures in survival analysis.

Holte SE, Randolph TW, Ding J, Tien J, McClelland RS, Baeten JM, Overbaugh J.

Stat Med. 2012 Aug 30;31(19):2086-97. doi: 10.1002/sim.5318. Epub 2012 Mar 13.

PMID:
22415871
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.

Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, Chipato T, Jaffe H, Lakhi S, Karita E, Porter K, Meyer L, Touloumi G; CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group.

PLoS One. 2012;7(3):e32369. doi: 10.1371/journal.pone.0032369. Epub 2012 Mar 6.

PMID:
22412867
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Novel use of surveillance data to detect HIV-infected persons with sustained high viral load and durable virologic suppression in New York City.

Terzian AS, Bodach SD, Wiewel EW, Sepkowitz K, Bernard MA, Braunstein SL, Shepard CW.

PLoS One. 2012;7(1):e29679. doi: 10.1371/journal.pone.0029679. Epub 2012 Jan 24.

PMID:
22291892
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count.

Grinsztejn B, Smeaton L, Barnett R, Klingman K, Hakim J, Flanigan T, Kumarasamy N, Campbell T, Currier J; PEARLS study team of the ACTG.

Antivir Ther. 2011;16(7):1057-62. doi: 10.3851/IMP1872.

PMID:
22024521
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection.

Haubrich RH, Riddler SA, Ribaudo H, Direnzo G, Klingman KL, Garren KW, Butcher DL, Rooney JF, Havlir DV, Mellors JW; AIDS Clinical Trials Group (ACTG) A5160 and A5142 Study Teams.

AIDS. 2011 Nov 28;25(18):2269-78. doi: 10.1097/QAD.0b013e32834d0c20.

PMID:
21941167
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Drug resistance mutations in HIV pol sequences from Argentinean patients under antiretroviral treatment: subtype, gender, and age issues.

Jones LR, Moretti F, Calvo AY, Dilernia DA, Manrique JM, Gómez-Carrillo M, Salomón H.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):949-55. doi: 10.1089/AID.2011.0287. Epub 2011 Nov 22.

PMID:
21936717
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk